Issue 42, 2024

Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation

Abstract

Toll-like receptor 7/8 (TLR-7/8) agonists serve as a promising class of pattern recognition receptors that effectively evoke the innate immune response, making them promising immunomodulatory agents for tumor immunotherapy. However, the uncontrollable administration of TLR-7/8 agonists frequently leads to the occurrence of severe immune-related adverse events (irAEs). Thus, it is imperative to strategically design tumor-microenvironment-associated biomarkers or exogenous stimuli responsive TLR-7/8 agonists in order to accurately evaluate and activate innate immune responses. No comprehensive elucidation has been documented thus far regarding TLR-7/8 immune agonists that are specifically engineered to enhance immune activation. In this feature article, we provide an overview of the advancements in TLR-7/8 agonists, aiming to enhance the comprehension of their mechanisms and promote the clinical progression through nanomedicine strategies. The current challenges and future directions of cancer immunotherapy are also discussed, with the hope that this work will inspire researchers to explore innovative applications for triggering immune responses through TLR-7/8 agonists.

Graphical abstract: Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation

Article information

Article type
Feature Article
Submitted
18 Ақп. 2024
Accepted
25 Сәу. 2024
First published
26 Сәу. 2024

Chem. Commun., 2024,60, 5474-5485

Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation

L. Gu, X. Kong, M. Li, R. Chen, K. Xu, G. Li, Y. Qin and L. Wu, Chem. Commun., 2024, 60, 5474 DOI: 10.1039/D4CC00792A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements